Phase I study of patupilone and RAD001 in patients with refractory solid tumoUr malignancy.
Phase of Trial: Phase I
Latest Information Update: 15 Nov 2013
At a glance
- Drugs Everolimus (Primary) ; Patupilone (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 13 Jun 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 13 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jun 2012 Actual end date Feb 2011 added as reported by ClinicalTrials.gov.